Is your treatment getting denied?

Each year, insurance companies and pharmacy benefit managers (PBMs) make adjustments to the list of prescriptions they cover. These lists are called formularies. This year, some companies have made changes to their formularies that may impact the prescriptions you are able to access. 

If you’ve received a letter saying that your psoriatic disease treatment is no longer covered by your insurance plan, this could mean that your formulary has changed. This letter may be from your insurance company or from the PBM that manages your drug benefits.

While this may seem like alarming news, NPF is here to help. If you’ve received a letter or are having other problems accessing your medications, get in touch with an NPF patient navigator. Your navigator will work with you one-on-one to help you appeal the denial and make sure you stay on your treatment.  

Insurance resources are a click away

Making decisions when it comes to your health without all the facts can be hard. Request info to help you get the most out of your insurance


Driving discovery, creating community

For more than 50 years, we’ve been driving efforts to cure psoriatic disease and improve the lives of those affected. But there’s still plenty to do! Learn how you can help our advocacy team shape the laws and policies that affect people with psoriasis and psoriatic arthritis – in your state and across the country. Help us raise funds to support research by joining Team NPF, where you can walk, run, cycle, play bingo or create your own fundraising event. If you or someone you love needs free, personalized support for living a healthier life with psoriatic disease, contact our Patient Navigation Center. And keep the National Psoriasis Foundation going strong by making a donation today. Together, we will find a cure.

Recent Advance Posts

Dr. Ronald Prussick
A chance meeting with an inspiring mentor channels a promising physician into a...
hand with arthritis on mouse beside keyboard
We take many common movements and activities for granted – until they become...
genital psoriasis
One in four of you will experience genital psoriasis. Relief starts with having...
image of foam with the words "FDA approved"
Lexette, a topical corticosteroid foam, aims to reduce plaques.
FDA Approved Topical
The latest topical lotion aims to reduce plaque and clear your skin.
FDA Approval Skyrizi
The latest interleukin-23 inhibitor is aimed at adults with moderate-to-severe...
Jawbone, chatter teeth
Candace Primack experienced mysterious jaw pain during graduate school. Fifteen...
Don’t turn taking your meds into an uphill battle. Get the facts and stay the...
The first two AAD-NPF guidelines in a series of six tackle biologics and...